Meningitis (Streptococcus pneumoniae)

Overview

Plain-Language Overview

Meningitis (Streptococcus pneumoniae) is an infection that affects the protective membranes covering the brain and spinal cord, called the meninges. This condition primarily involves the central nervous system and can cause serious health problems. The infection leads to inflammation, which can result in symptoms like fever, headache, neck stiffness, and confusion. It is caused by the bacteria Streptococcus pneumoniae, which can enter the bloodstream and reach the meninges. If untreated, it can lead to severe complications such as brain damage, hearing loss, or even death. Early recognition of symptoms is crucial for diagnosis and management.

Clinical Definition

Meningitis (Streptococcus pneumoniae) is an acute inflammation of the meninges caused by the encapsulated gram-positive diplococcus Streptococcus pneumoniae. It is the most common cause of bacterial meningitis in adults and young children, leading to a rapid onset of symptoms due to bacterial invasion of the subarachnoid space. The pathogenesis involves bacterial colonization of the nasopharynx, bloodstream invasion, and crossing of the blood-brain barrier, triggering a robust inflammatory response. This inflammation results in increased intracranial pressure, cerebral edema, and disruption of the blood-brain barrier. Clinically, it presents with fever, neck stiffness, altered mental status, and photophobia. The condition is a medical emergency due to its high morbidity and mortality without prompt treatment.

Inciting Event

Nasopharyngeal colonization by Streptococcus pneumoniae precedes invasion.
Upper respiratory tract infection often precedes bacterial dissemination to the meninges.
Bacteremia allows hematogenous spread of bacteria across the blood-brain barrier.
Direct extension from adjacent infections like otitis media or sinusitis triggers meningitis.

Latency Period

Symptom onset typically occurs within hours to 2 days after bacterial invasion of the meninges.
Rapid progression from initial nonspecific symptoms to severe neurological signs is common.
Latency is generally short due to acute inflammatory response.

Diagnostic Delay

Early symptoms mimic viral infections, leading to initial misdiagnosis.
Lack of classic meningeal signs in some patients delays suspicion.
Prior antibiotic use can mask culture results, complicating diagnosis.
Overlap with other CNS infections or encephalitis may confuse clinical picture.

Patient Population

Children under 5 years and elderly adults are most commonly affected by pneumococcal meningitis.
Immunocompromised patients including those with HIV or malignancy have increased incidence.
Patients with anatomical defects such as CSF leaks or cochlear implants are predisposed.
Individuals without prior pneumococcal vaccination are at higher risk.

Risk Factors

Splenectomy or functional asplenia increases susceptibility due to impaired clearance of encapsulated bacteria.
Immunocompromised states such as HIV/AIDS or immunosuppressive therapy raise infection risk.
Chronic otitis media or sinusitis can serve as a source of bacterial spread to the meninges.
Head trauma or neurosurgical procedures breach protective barriers facilitating bacterial entry.
Age extremes, especially infants and elderly, have higher risk due to immature or waning immunity.

Clinical Presentation

Signs & Symptoms

Headache, fever, and neck stiffness as classic triad
Photophobia and nausea/vomiting due to meningeal irritation
Altered mental status ranging from confusion to coma
Seizures may occur in severe cases
Cold extremities and signs of shock in systemic sepsis

History of Present Illness

Acute onset of high fever, headache, and neck stiffness is typical.
Photophobia and altered mental status develop as inflammation progresses.
Nausea and vomiting often accompany increased intracranial pressure.
Rapid deterioration with seizures or focal neurological deficits may occur.

Past Medical History

Recent upper respiratory infections or sinusitis increase risk.
History of splenectomy or sickle cell disease predisposes to infection.
Chronic ear infections or prior neurosurgery may be relevant.
Lack of pneumococcal vaccination is a significant risk factor.

Family History

No strong familial patterns are associated with pneumococcal meningitis.
Rare genetic immunodeficiencies affecting complement or antibody production may increase susceptibility.
Family history of recurrent infections may suggest underlying immune defects.

Physical Exam Findings

Nuchal rigidity indicating meningeal inflammation
Fever and altered mental status reflecting systemic infection and CNS involvement
Kernig sign and Brudzinski sign positive due to meningeal irritation
Petechial or purpuric rash may be present in severe cases
Tachycardia and hypotension in cases progressing to sepsis

Diagnostic Workup

Diagnostic Criteria

Diagnosis of meningitis caused by Streptococcus pneumoniae is established by lumbar puncture with cerebrospinal fluid (CSF) analysis showing elevated opening pressure, neutrophilic pleocytosis, low glucose, and elevated protein. Gram stain and culture of the CSF confirm the presence of gram-positive diplococci. Blood cultures are often positive and support the diagnosis. Additional tests such as PCR can detect pneumococcal DNA in CSF when cultures are negative. Clinical presentation combined with CSF findings and microbiological confirmation is essential for definitive diagnosis.

Pathophysiology

Key Mechanisms

Bacterial invasion of the subarachnoid space leading to intense inflammatory response.
Capsular polysaccharide of Streptococcus pneumoniae evades phagocytosis, enhancing virulence.
Neutrophil recruitment and release of inflammatory cytokines cause meningeal edema and increased intracranial pressure.
Disruption of the blood-brain barrier facilitates further bacterial entry and immune cell infiltration.
Cerebral vasculitis and microthrombi formation contribute to ischemic injury and neurological deficits.

Involvement	Details
Organs	Brain is the primary organ affected, with inflammation causing cerebral edema, increased intracranial pressure, and potential neuronal injury.
Organs	Lungs may be a source of Streptococcus pneumoniae infection leading to hematogenous spread to the meninges.
Tissues	Meninges are inflamed in pneumococcal meningitis, leading to characteristic clinical symptoms such as neck stiffness and headache.
Tissues	Blood-brain barrier disruption occurs due to inflammation, allowing immune cells and antibiotics to enter the CNS.
Cells	Neutrophils are the primary immune cells infiltrating the cerebrospinal fluid, mediating bacterial clearance and inflammation.
Cells	Microglia act as resident CNS macrophages, initiating the inflammatory response to Streptococcus pneumoniae infection.
Chemical Mediators	Tumor necrosis factor-alpha (TNF-α) is a key pro-inflammatory cytokine driving meningeal inflammation and blood-brain barrier disruption.
	Interleukin-1 beta (IL-1β) promotes leukocyte recruitment and fever in bacterial meningitis.
	Matrix metalloproteinases (MMPs) contribute to blood-brain barrier breakdown and tissue damage.

Treatments

Pharmacological Treatments

Ceftriaxone
- Mechanism:
  - Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
- Side effects:
  - Allergic reactions
  - Diarrhea
  - Biliary sludging
- Clinical role:
  - First-line
Vancomycin
- Mechanism:
  - Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors, effective against resistant strains.
- Side effects:
  - Nephrotoxicity
  - Ototoxicity
  - Red man syndrome
- Clinical role:
  - First-line
Dexamethasone
- Mechanism:
  - Reduces meningeal inflammation and cerebral edema by inhibiting pro-inflammatory cytokine production.
- Side effects:
  - Hyperglycemia
  - Immunosuppression
  - Gastrointestinal bleeding
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Supportive care with intravenous fluids to maintain hydration and electrolyte balance.
Oxygen supplementation and mechanical ventilation if respiratory failure occurs.
Monitoring and management of increased intracranial pressure with head elevation and possible neurosurgical intervention.

Prevention

Pharmacological Prevention

Pneumococcal conjugate vaccine (PCV13) recommended for children and high-risk adults
Pneumococcal polysaccharide vaccine (PPSV23) for adults over 65 and immunocompromised patients
Prophylactic antibiotics such as rifampin for close contacts in certain outbreaks
Prompt empiric antibiotic therapy to prevent progression in suspected cases

Non-pharmacological Prevention

Hand hygiene and respiratory etiquette to reduce transmission
Avoidance of smoking which impairs mucociliary clearance
Early treatment of otitis media and sinusitis to prevent spread
Screening and vaccination programs in high-risk populations
Use of protective equipment in healthcare settings to prevent nosocomial spread

Outcome & Complications

Complications

Septic shock with multiorgan failure
Increased intracranial pressure causing brain herniation
Cerebral edema and vasculitis leading to ischemic stroke
Hydrocephalus from impaired CSF absorption
Subdural empyema or brain abscess formation

Short-term Sequelae	Long-term Sequelae
Hearing loss due to cochlear nerve involvement or labyrinthitis Seizures during acute illness Cognitive impairment and delirium Focal neurologic deficits such as cranial nerve palsies Persistent fever and systemic inflammatory response	Permanent sensorineural hearing loss is the most common chronic complication Cognitive deficits including memory and attention impairment Seizure disorders developing post-infection Hydrocephalus requiring shunting Motor deficits from stroke or brain injury

Differential Diagnoses

Meningitis (Streptococcus pneumoniae) versus Meningitis (Neisseria meningitidis)

Meningitis (Streptococcus pneumoniae)	Meningitis (Neisseria meningitidis)
Gram-positive lancet-shaped diplococci	Gram-negative diplococci
Common in older adults and infants	Common in children and young adults
Often follows pneumonia or sinusitis	Close contact or outbreaks in crowded settings
May require vancomycin plus ceftriaxone due to resistance	Responds well to penicillin or third-generation cephalosporins

Meningitis (Streptococcus pneumoniae) versus Meningitis (Haemophilus influenzae type b)

Meningitis (Streptococcus pneumoniae)	Meningitis (Haemophilus influenzae type b)
Gram-positive lancet-shaped diplococci	Small gram-negative coccobacilli
Affects all ages, especially elderly and immunocompromised	Primarily affects unvaccinated children under 5 years
No specific vaccination history required	Lack of Hib vaccination
May require vancomycin plus ceftriaxone due to resistance	Responds to third-generation cephalosporins

Meningitis (Streptococcus pneumoniae) versus Viral meningitis

Meningitis (Streptococcus pneumoniae)	Viral meningitis
CSF shows neutrophilic predominance, low glucose	CSF shows lymphocytic predominance, normal glucose
Often severe with rapid progression	Usually self-limited and less severe
Positive bacterial culture or antigen test in CSF	Positive viral PCR in CSF

Meningitis (Streptococcus pneumoniae) versus Tuberculous meningitis

Meningitis (Streptococcus pneumoniae)	Tuberculous meningitis
Acute onset over hours to days	Subacute to chronic progression over weeks
CSF shows neutrophilic pleocytosis, moderately low glucose	CSF shows lymphocytic pleocytosis, very low glucose, high protein
Positive Gram stain and culture for Streptococcus pneumoniae	Positive acid-fast bacilli stain or PCR for Mycobacterium tuberculosis

Meningitis (Streptococcus pneumoniae) versus Brain abscess

Meningitis (Streptococcus pneumoniae)	Brain abscess
Diffuse meningeal enhancement without focal mass	Ring-enhancing lesion with central necrosis on MRI/CT
Diffuse meningeal signs with rapid onset	Focal neurological deficits develop gradually
CSF shows neutrophilic pleocytosis and positive culture	CSF often normal or mildly abnormal; diagnosis by imaging and aspiration